Patent ID: 8846770

Claim:
A pharmaceutical composition for otic administration comprising: (i) a therapeutically effective amount of a multiparticulate aural pressure modulating agent, or pharmaceutically acceptable salt thereof; (ii) a copolymer of polyoxyethylene and polyoxypropylene in an amount sufficient to provide a gelation temperature of between about 19° C. and about 42° C., a gelation viscosity between about 15,000 cP and about 1,000,000 cP; and a non-gelation viscosity that allows injection with a 18-31 gauge needle through the tympanic membrane on or near the round window membrane; and (iii) having an osmolarity of 100-500 mOsm/L; wherein the pharmaceutical composition for otic administration provides a sustained release of the aural pressure modulating agent to the inner ear for a period of at least 5 days after a single administration; wherein the aural pressure modulating agent is a vasopressin receptor modulator, prostaglandin receptor modulator, estrogen-related receptor beta modulator, a calcium channel blocker, or combinations thereof; provided that the aural pressure modulating agent is a non-corticosteroid aural pressure modulating agent.